James Garner

Company: Kazia Therapeutics Limited

Job title: Chief Executive Officer

Seminars:

Panel Discussion: GBM AGILE Goes Worldwide: Taking a Deep Dive Into How Well It Has Worked So Far & What Promise It Brings With Expansion 9:00 am

Reflecting on more than 3 years of progress – lessons learned to date and plans/goals for the next 3+ years Stakeholder perspectives – industry, clinical/scientific investigators, and patient advocates Adaptive Global Innovative Learning Environment (AGILE): Focusing on the “LE” in AGILERead more

day: Conference Day One

PI3K Inhibition With Hypoinsulinaema – A Novel Approach to Maximizing the Impact of Targeted Therapy 12:00 pm

Reviewing the role of the PI3K pathway in glioblastoma Evaluating the rationale for combining PI3K pathway inhibition with hypoinsulinaemia Overview of an ongoing clinical trial to explore the combinationRead more

day: Conference Day Two